PET/MRI scan test to predict outcomes in endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies whether special scans (PET/MRI) can help predict how well endometrial cancer patients will do. You may be asked to get these scans before surgery, and your results may help classify your cancer risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with the main type of endometrial cancer confirmed by tissue testing (biopsy/surgery pathology).
- You are older than 18 years.
- Your doctor thinks you can safely have surgery (or at least there are no major medical reasons you can’t).
- You can safely have the required scans before surgery, and the tumor can be seen on imaging.
- You can tolerate the scan environment (for example, you are not severely claustrophobic).
- You can give signed informed consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a computer model powered by artificial intelligence can better predict outcomes for people with endometrial cancer or related conditions. It uses patient data and tissue samples to see if the model can help doctors choose the best care.
This trial studies whether MRI can improve diagnosis and surgical planning for people with deep endometriosis before they have laparoscopic surgery. It may help you if you have deep endometriosis and are already scheduled for an MRI and surgery.
This study uses a combined PET/MRI scan to better see endometriosis in people who are already scheduled for laparoscopic surgery. It may help find spots of endometriosis that are hard to see with other tests.
This study uses special PET scans to better see and understand pelvic tumors. It may help doctors plan treatment more accurately. You may be able to join if you have a pelvic tumor and can have surgery or a biopsy.
This study uses MRI scans and tissue samples to predict the molecular type and outlook of endometrial cancer, which may help guide treatment decisions.
This trial uses a combined PET and MRI scan to see if it can better identify the spread of cervical cancer before treatment. It may help guide more personalized care.
Hear when a new Endometrium Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.